Sign In
Buy PTC
$139.72
-2.62 (-1.84%)
At Close: Jun 03, 2026
Why Did PTC Therapeutics Stock Fall On Monday Despite Mid-Stage Study For Huntington's Hits Primary Goal?
04:54pm, Monday, 05'th May 2025
PTC Therapeutics, Inc. PTCT on Monday announced results from the Phase 2 PIVOT-HD study of PTC518 (votoplam) in Stage 2 and Stage 3 Huntington's disease (HD) patients.
PTC518 PIVOT-HD Study Achieves Primary Endpoint
07:00am, Monday, 05'th May 2025
- Study met primary endpoint with dose-dependent blood HTT protein lowering at Week 12 - - Favorable dose-dependent trends across clinical scales in Stage 2 patients at Month 12 - - Signals of dose-de
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Thursday, 01'st May 2025
WARREN, N.J. , May 1, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that on April 25, 2025, the company approved non-statutory stock options to purchase an aggregate of 7
PTC's Q2 Earnings & Revenues Top, Improve Y/Y, 2025 Outlook Tweaked
09:50am, Thursday, 01'st May 2025
PTC's Q2 performance is driven by solid recurring revenues amid a tough sales backdrop. Fiscal 2025 view is revised based on potential macro volatility.
PTC Inc. (PTC) Q2 2025 Earnings Call Transcript
11:53pm, Wednesday, 30'th Apr 2025
PTC Inc. (NASDAQ:PTC ) Q3 2025 Earnings Conference Call April 30, 2025 5:00 PM ET Company Participants Matt Shimao - Head of Investor Relations Neil Barua - President & Chief Executive Officer Kristia
Compared to Estimates, PTC Inc. (PTC) Q2 Earnings: A Look at Key Metrics
06:30pm, Wednesday, 30'th Apr 2025
The headline numbers for PTC Inc. (PTC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimate
PTC Inc. (PTC) Surpasses Q2 Earnings and Revenue Estimates
06:20pm, Wednesday, 30'th Apr 2025
PTC Inc. (PTC) came out with quarterly earnings of $1.79 per share, beating the Zacks Consensus Estimate of $1.38 per share. This compares to earnings of $1.46 per share a year ago.
PTC ANNOUNCES SECOND FISCAL QUARTER 2025 RESULTS
04:01pm, Wednesday, 30'th Apr 2025
Delivered solid execution in Q2'25 and exceeded guidance across all metrics Constant Currency ARR Growth of 10% Operating Cash Flow Growth of 12% Free Cash Flow Growth of 13% Proceeding with share re
PTC and Schaeffler Expand Strategic Relationship with Adoption of Windchill+ PLM
08:30am, Wednesday, 30'th Apr 2025
Leading global automotive and industrial supplier continues product development modernization with transition to cloud-based Windchill+ PLM Windchill+ offers speed of deployment, upgrade, and collabo
PTC Gearing Up to Report Q2 Earnings: Here's What to Expect
12:00pm, Monday, 28'th Apr 2025
PTC's Q2 performance is likely to have benefited from momentum across its PLM and CAD solutions, though competition and tough selling environment remain concerns.
- Label includes full spectrum of PKU patients - - European launch preparations underway - WARREN, N.J. , April 25, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the
PTC Therapeutics to Participate at Upcoming Investor Conferences
08:00am, Thursday, 24'th Apr 2025
WARREN, N.J. , April 24, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences: Bank of America Securities 2025 Health
Why PTC Inc. (PTC) is Poised to Beat Earnings Estimates Again
01:15pm, Wednesday, 23'rd Apr 2025
PTC Inc. (PTC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
PTC Inc. (PTC) Expected to Beat Earnings Estimates: Should You Buy?
11:06am, Wednesday, 23'rd Apr 2025
PTC Inc. (PTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2025 Financial Results
08:00am, Thursday, 17'th Apr 2025
WARREN, N.J. , April 17, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its first quarter 2025 financial res
